Herz

Papers
(The median citation count of Herz is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Neue Optionen zur Intensivierung der lipidsenkenden Therapie36
Light at the end of the tunnel?31
Predictive strength of inflammatory scores for in-hospital mortality in infective endocarditis22
Unexpected high level of severe events even in low-risk profile chest pain unit patients19
Lebenslanges Lernen in der Kardiologie: Durch Innovation erfolgreich13
Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care13
Outcome of edge-to-edge vs. surgical repair in patients with functional mitral regurgitation and reduced left ventricular function12
Evaluation of the acute effects of inhaled iloprost on aortic compliance in pulmonary arterial hypertension using invasive methods11
Präzisionsmedizin bei Diagnostik und Therapie von Kardiomyopathien10
Survey of clinical practice pattern in Germany’s certified chest pain units9
2022 ESC/ERS-Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie9
Early echocardiographic evaluation of right ventricular load adaptability after sequential combination treatment in pulmonary arterial hypertension9
Rhythmusstörungen8
Cardiac, possible cardiac, and likely non-cardiac origin of chest pain7
The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting7
Infarktbedingter kardiogener Schock6
Clinical review of sick sinus syndrome and atrial fibrillation6
Cannabinoids and the heart—a psychiatrist’s perspective6
Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy6
Therapie mit kardialen elektronischen implantierbaren Devices6
Precision medicine in the management of cardiac arrhythmias6
Rolle der Genetik in der Präzisionsmedizin der koronaren Herzkrankheit6
ESC-Leitlinie 2022 zum kardiovaskulären Assessment und Management von Patienten, die sich einer nichtkardiologischen Operation unterziehen5
Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI5
Neues zur Diagnostik und Therapie der Herzinsuffizienz5
A mix of aminophylline and heparin plus nitroglycerin can reduce bradycardia during rotational atherectomy on the right coronary artery and dominant circumflex artery5
Correlation between decreased plasma miR-29a and vascular endothelial injury induced by hyperlipidemia5
Long-term outcomes following double kissing crush or mini-culotte stenting for complex coronary bifurcation lesions: the EVOLUTE-CRUSH IV study5
Is lysosomal acid lipase activity associated with the presence and severity of coronary artery disease?5
Increased cardiovascular risk in patients with chronic kidney disease5
Cardiovascular evaluation of pregnant women with hypertrophic cardiomyopathy4
Cardiovascular disease in patients with chronic kidney disease4
Prognostic value of pulmonary artery diameter/aorta diameter ratio in patients with acute pulmonary embolism4
Neue Aspekte implantierbarer elektrischer kardialer Geräte4
Koronare CT-Angiographie und koronare Atherosklerose4
eCardiology4
Mind and body interventions in cardiology4
Technisches Rüstzeug für chronisch verschlossene Gefäße4
Erratum zu: ESC-Leitlinien 2023 zum Management der Endokarditis4
Real-world evidence for the use of subcutaneous implantable cardioverter–defibrillators in China: A single-center experience4
Safety and feasibility of same-day discharge following catheter ablation of atrial fibrillation: what is known and what needs to be explored?4
Interventionelle Therapie der Herzinsuffizienz3
Update zur Behandlung der Aortenklappenstenose bei symptomatischen und asymptomatischen Patienten3
Diagnostik und Therapie der Lungenembolie3
Environmental and climate cardiology: some environmental issues highlighted at the annual meetings of the German Society for Cardiology (DGK) from 2007 to 20233
Erratum to: Right ventricular failure in pulmonary hypertension: recent insights from experimental models3
Anticoagulation in special patient populations with atrial fibrillation3
Lipidsenkung: neue Substanzen und neue Konzepte3
Precision medicine in the management of valvular heart disease3
Epicardial adipose tissue as a prognostic marker in acute pulmonary embolism3
On the gap between objective and perceived risks of COVID-193
Has COVID-19 changed the spectrum of arrhythmias and the incidence of sudden cardiac death?3
ESC/EACTS-Leitlinien 2021 zum Management von Herzklappenerkrankungen3
Impact of residual coronary artery disease on left ventricular function after percutaneous coronary intervention: a two-dimensional strain echocardiography study3
Pulmonale Hypertonie bei Lungenerkrankungen3
Erratum zu: Gesättigte Fettsäuren und kardiovaskuläres Risiko: Ist eine Revision der Ernährungsempfehlungen angezeigt?2
Leitlinien 2021 – im Rückblick der Blick voraus?2
Nutzen der kardialen Magnetresonanzdiagnostik für Patienten mit Herzrhythmusstörungen2
New categorization of chest pain: noncardiac is in, atypical is out!2
Morphologische und funktionelle Diagnostik der koronaren Herzkrankheit mittels Computertomographie2
Statinintoleranz und statinassoziierte Muskelschmerzen2
Mapping atrial fibrillation2
ESC-Leitlinien 2021 zur Schrittmacher- und Resynchronisationstherapie2
Brustschmerz und kardiovaskuläre Erkrankungen bei Frauen2
Acute prevention of a heart attack2
Update Kardioonkologie2
Akute Herzinsuffizienz und kardiogener Schock2
Management des akuten Koronarsyndroms2
Protecting healthcare personnel and patients over 3 years of COVID-192
Prävention des plötzlichen Herztods2
Chronic thromboembolic pulmonary hypertension—medical, interventional, and surgical therapy2
Guideline-endorsed follow-up after percutaneous valve therapies—non-attendance of TAVI and MitraClip patients2
Catheter-directed therapy in pulmonary embolism2
Aktuelle Anwendungen der Hypnose auf dem Gebiet der kardialen Elektrophysiologie2
Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes2
Herz und Diabetes2
ESC-Leitlinie 2022 onkologische Kardiologie2
Association between lipoprotein(a) and cardiovascular disease in patients undergoing coronary angiography2
Sterblichkeit bei Patienten mit ST-Strecken-Hebungs-Myokardinfarkt in Deutschland2
Kalzifizierte Stenosen richtig behandeln2
Non-transvenous ICD therapy: current status and beyond2
Luftverschmutzung, Lärm und Hypertonie2
Kardiale Bildgebung – mehr als reine Diagnostik1
Burden of disease in Germany attributed to ambient particulate matter pollution1
Novel biomarkers identified by weighted gene co-expression network analysis for atherosclerosis1
Diabetes, obesity, and cardiovascular disease—what is the impact of lifestyle modification?1
Die neue ESC-Leitlinie zum Management ventrikulärer Tachyarrhythmien1
Qualitätserfassung in der Herzmedizin1
Qualitätssicherung in der Kardiologie mit Routinedaten1
Kathetergestützter Edge-to-edge-Mitralklappenrepair (M-TEER) in Deutschland1
Kardiologische Versorgungsforschung1
Healthcare provision of transcatheter aortic valve implantation in Germany1
Aktuelle Technologien zur interventionellen Therapie der Trikuspidalklappeninsuffizienz1
Atrial fibrillation increases the risk of new-onset myocardial infarction amongst working-age population: a propensity-matched study1
A practical approach for the treatment of post-COVID symptoms1
RAAS inhibition and beyond—cardiovascular medications in patients at risk of or affected by COVID-191
Hauptstammintervention – Ist ein Stent doch besser als zwei?1
Depression screening in patients with coronary heart disease1
Herzinsuffizienzleitlinien 2021 der ESC1
Effects of TCFA on stent neointimal coverage at 9 months after EXCEL drug-eluting stent implantation assessed by OCT1
Gesättigte Fettsäuren und kardiovaskuläres Risiko1
Accuracy of VO2 estimation according to the widely used Krakau formula for the prediction of cardiac output1
Management strategies in heart failure with preserved ejection fraction1
Erratum to: Artificial intelligence in cardiovascular imaging and intervention1
E-cigarettes and vaping, new spotlight on smoking as an old cardiovascular risk factor?1
Neuer Standard: Kombinationstherapie zur Behandlung von Fettstoffwechselstörungen1
Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?1
Erratum to: Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic1
Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future1
Cardiac disease-induced trauma and stress-related disorders1
Was ist neu im Management der peripheren arteriellen Verschlusskrankheit und der aortalen Erkrankungen?1
Erratum to: Diabetes, obesity, and cardiovascular disease—what is the impact of lifestyle modification?1
Endocardial left ventricular pacing1
Erhöhter Blutdruck und Bluthochdruck1
Current devices and interventions in mitral regurgitation1
Myokardiale Revaskularisation1
Geschlechtsspezifische Diagnostik und Therapie von Herz-Kreislauf-Erkrankungen1
Anwendung der Videosprechstunde in der kardiovaskulären Lipidbehandlung1
Komplexe Interventionen – eine Herausforderung!1
Effects of cannabis use on the heart1
Renal denervation plus cardiac ablation vs. cardiac ablation alone for patients with atrial fibrillation and uncontrolled arterial hypertension1
The effect of high-power short-duration pulmonary vein isolation on PWPT—a predictor of paroxysmal atrial fibrillation1
Digital health solutions in the screening of subclinical atrial fibrillation1
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions1
The predictive value of PRECISE-DAPT score for long-term mortality in patients with acute coronary syndrome complicated by cardiogenic shock1
Zukunft der interventionellen Kardiologie1
Atrial remodeling and atrial fibrillation recurrence after catheter ablation1
Computed tomography to guide transcatheter aortic valve implantation0
Klinische Anwendung der kardialen Computertomographie0
Erratum zu: Diagnose und Behandlung der kardialen Amyloidose0
Diagnostik und Therapie von Synkopen0
The changing spectrum of cardiovascular emergencies during the COVID-19 pandemic0
Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review0
Association between MTHFR C677T polymorphism and risk of coronary artery disease in the Chinese population: meta-analysis0
Kardiovaskuläres Management von Patienten bei nichtkardialen Operationen0
Herzinsuffizienz mit erhaltener Ejektionsfraktion (HFpEF)0
Rhythmologische und metabolische Kontrolle0
Telemedizinische Versorgungskonzepte bei Herzinsuffizienz: Status und Zukunft0
Aorten- und Herzklappenerkrankungen, Kardiomyopathien und Herzinsuffizienz in der Schwangerschaft0
Perspektiven der kardiovaskulären Präzisionsmedizin – von der Prävention zur Intervention0
Management von Kardiomyopathien0
Akuter Thoraxschmerz im Wandel0
Periphere arterielle Verschlusskrankheit (pAVK)0
Use of sacubitril/valsartan in patients with heart failure in primary care in Germany: the AURORA-HF noninterventional study0
Back to the roots of cardiometabolic care0
Predictive value of coronary artery computed tomography-derived fractional flow reserve for cardiovascular events in patients with coronary artery disease0
Kardiovaskuläre Interventionen0
ESC-Leitlinien 2024: Was ist neu? Was ist besonders wichtig?0
Estimates of excess mortality during the COVID-19 pandemic strongly depend on subjective methodological choices0
Urantide alleviates atherosclerosis-related liver and kidney injury via the Wnt/β-catenin signaling pathway in ApoE(−/−) mice0
Methamphetamine-induced cardiotoxicity: in search of protective transcriptional mechanisms0
Analysis of risk factors for systemic inflammatory response syndrome in patients after transcatheter aortic valve replacement0
First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study0
Patent foramen ovale—When to close and how?0
Bifurkationsläsionen0
Pulmonary hypertension0
Alcohol consumption—none is better than a little0
Erratum to: Efficacy of sacubitril–valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a syste0
Update kardiovaskuläre Prävention 20250
Kardiale Kontraktilitätsmodulation0
Diagnose und Behandlung der kardialen Amyloidose0
Linksatrialer Vorhofohrverschluss0
Europäische Leitlinien Herzinsuffizienz: medikamentöse Therapie0
Pushing the limits for interventional treatment of aortic valve stenosis0
Obesity and heart failure—the role of GLP-1 receptor agonists0
SARS-CoV-2, vaccination or autoimmunity as causes of cardiac inflammation. Which form prevails?0
Kosten-Nutzen-Analyse neuer Lipidsenker0
Artificial intelligence in cardiovascular imaging and intervention0
E-Health: digitale Brücken im Versorgungssystem0
Erratum zu: Diagnostik und Therapie der Lungenembolie0
Psychokardiologie – auf dem Weg zur sonnigen Seite der Straße0
Neue Leitlinien 2023: viele Empfehlungen, aber nur wenig Überraschendes0
Clinical characteristics of delirium in older patients with first-ever acute myocardial infarction who underwent percutaneous coronary intervention0
Healthcare 4.0 – Medizin im Wandel0
Neue Entwicklungen bei kabellosen Schrittmachersystemen0
Management des akuten Koronarsyndroms ohne ST-Strecken-Hebung0
Prevalence of atrial fibrillation0
Left atrial appendage orifice morphology in sickness and in health0
Supraventrikuläre Tachykardien0
2 Jahre COVID-19-Pandemie – was haben wir gelernt?0
Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?0
Lärmbelästigung in der deutschen Allgemeinbevölkerung0
PCSK9-Hemmung – ein Update0
Bildgebende Diagnostik der kardialen Sarkoidose0
Rechtliche Aspekte in der digitalen Kardiologie0
Management des akuten Koronarsyndroms0
ESC-Leitlinien 2022: neue Leitlinien und neue Herausforderungen in Europa0
Psychological burden in patients with angina and unobstructed coronary arteries—underestimated, underexplored, undertreated0
Comorbidities in heart failure with preserved ejection fraction0
Evaluation of risk factors for long-term atrial fibrillation development in patients undergoing typical atrial flutter ablation: a multicenter pilot study0
New therapeutic approaches for the treatment of hypertriglyceridemia0
Kanadas Leitlinienempfehlung zu Alkohol und Gesundheit0
Mechanische Kreislaufunterstützungssysteme0
T-TEER: Beschreibung eines Entwicklungsprozesses0
Lipoproteinapherese0
Outcomes of electronic health interventions for patients with heart failure: a network meta-analysis0
The COVID-19 pandemic in China: from dynamic zero-COVID to current policy0
Pulmonalvenenisolation bei Vorhofflimmern mittels „pulsed field ablation“0
Prognostic value of extended cardiac risk assessment before elective open abdominal aortic surgery0
Outcome of a polymer-free drug-coated coronary stent in bifurcation lesions—Pilot registry with serial OCT imaging0
Herz und Blut: klonale Hämatopoese0
European Society of Cardiology(ESC)-Leitlinie Vorhofflimmern 20240
Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic0
Sportkardiologie0
Exploring Roemheld syndrome: a comprehensive review with proposed diagnostic criteria0
Kardiovaskuläre Medizin – Herzrhythmusstörungen0
Neue ESC-Leitlinien 2021 zur Prävention von kardiovaskulären Erkrankungen0
The future of heart failure with preserved ejection fraction0
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany0
Kardiale Amyloidose und Aortenklappenstenose0
Relationship between platelet mass index and postoperative atrial fibrillation after elective coronary artery bypass surgery: a retrospective study0
ESC-Leitlinien 2023 zum Management der Endokarditis0
Cardiac proteostasis in obesity and cardiovascular disease0
Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation0
Post-COVID—More than chronic fatigue?0
Predictive value of PHR and FHR for in-hospital mortality risk in patients with acute myocardial infarction0
Right ventricular failure in pulmonary hypertension: recent insights from experimental models0
Katheterablation ventrikulärer Tachykardien – Update 20230
Heart rate variability as a predictor of successful catheter-guided pulmonary vein isolation for atrial fibrillation0
Assessment of proarrhythmic ventricular electrophysiological remodeling in patients with rheumatoid arthritis0
Life’s Essential 8 and mortality among adults with early-onset cardiovascular diseases0
Herz und Diabetes0
AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR-Leitlinie 2021 zum Thoraxschmerz0
Neuroimmune crosstalk0
Environmental factors and their impact on the COVID-19 pandemic0
Interaction of alcohol and other potentially cardiotoxic substances with the cardiovascular system0
Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension0
Kardiovaskuläre Therapie bei chronischer Nierenerkrankung0
Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure0
Acute atrial infarction: a relatively neglected and under-recognized entity in clinical practice0
Herzinsuffizienz: Leitlinien-Update der ESC 20230
Mechanoenergetische Defekte bei Herzinsuffizienz0
Herzinsuffizienz-Epidemie: Mechanismen erforschen, Herzen heilen0
Effect of different intensity exercises on cardiopulmonary function and quality of life of patients with chronic heart failure0
Management des chronischen Koronarsyndroms0
Vagal stimulation in heart failure0
Wuhan 3 years after the outbreak of the pandemic—cardiological insights and perspectives0
Is an accurate self-perceived health risk beneficial for patients to minimize prehospital delay time at onset of a ST-segment elevated myocardial infarction (STEMI)?0
His-Bündel- und Linksschenkelstimulation0
Prähospitale Reanimationen0
Aktuelles zur Herz-Nieren-Interaktion0
ERC-Leitlinien 2021 zur kardiopulmonalen Reanimation0
Effects of hydroxychloroquine on atrial electrophysiology in in silico wild-type and PITX2+/- atrial cardiomyocytes0
Kardiovaskuläre Pharmakotherapie im Alter0
Assessing the efficacy of renal denervation in patients with resistant arterial hypertension0
Predictive role of peak VO2 for short- and long-term major adverse cardiac events in patients with high cardiovascular risk0
Vorhofflimmern0
Mechanism of action of aloperine in the treatment of pulmonary arterial hypertension based on network pharmacology and molecular docking methods0
Cardiac surgery during the COVID-19 pandemic0
Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes0
0.041511058807373